ArticleInternational immunopharmacology2022

Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.

Awatef Ben Jemaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.